6, which can be converted into the [3.3.0] system 7 by simple
heating. These two isomers can be separately reduced, to
provide access to a wide range of cyclopentylglycine deriva-
tives, with complete regio-, diastereo- and enantio-control.
We thank Dr A. S. F. Boyd and Dr R. Fergusson for NMR and
mass spectra, the EPSRC for financial support, and we
acknowledge the use of the EPSRC’s Chemical Database
Service at Daresbury.
Notes and references
† Selected data for 6: C17H21NO3; dH(CDCl3) 1.1 (3H, t, J 7.2), 1.5 (3H, d,
J 6.6), 2.4 (2H, m), 3.05 (1H, q, J 6.6), 3.55 (1H, m), 3.7 (1H, d, J 9.1), 3.95
(2H, q, J 7.2), 5.3 (1H, dd, J 7.4, 0.7), 5.8 (1H, dd, J 3.5, 1.7), 5.95 (1H, dd,
J 1.7, 0.7), 7.2–7.4 (5H, m); dC(CDCl3) 14.15 (CH3), 20.47 (CH3), 34.16
(CH2), 47.20 (CH), 60.52 (CH2), 65.68 (CH), 69.85 (CH), 87.35 (CH),
127.66 (CH), 128.25 (2 3 CH), 128.30 (2 3 CH), 129.49 (CH), 135.17
(CH), 141.91 (C), 169.90 (C).
‡ Crystal data for 7. A single crystal of 7 was grown by slow evaporation
of 40–60 pet. ether at rt and coated in Nujol and mounted on a glass fibre
covered with vacuum grease for data collection with a Bruker P4
diffractometer14 at 160 K. Colourless plate, 0.12 3 0.72 3 0.34 mm,
C17H21NO3, M = 287.35, monoclinic, space group P21, a = 6.0734 (4), b
= 13.0445 (9), c = 10.1045(7) Å , b = 98.280(5)°, U = 792.18(13) Å3, Z
= 2, m(Mo–Ka) = 0.082 mm21. Data measured = 3180, unique data =
1593, R = 0.0778 on all data (wR2 = 0.0306). Absolute structure parameter
= 3.5(19), so the absolute structure could not be confirmed from the X-ray
data. Crystallographic computing was performed using the SHELXTL15
b006683o/ for crystallographic data in .cif format.
Scheme 2 Possible mechanism for the formation of 6 and 7; heterolytic
bond cleavage of 7 would also be consistent with its thermolysis to 6. [R*
= (S)-1-phenylethyl].
1 R. Hirschmann, Angew. Chem., Int. Ed. Engl., 1991, 30, 1278.
2 P. D. Bailey, R. D. Wilson and G. R. Brown, J. Chem. Soc., Perkin
Trans. 1, 1991, 1337; P. D. Bailey, G. R. Brown, F. Korber, A. Reid and
R. D. Wilson, Tetrahedron: Asymmetry, 1991, 2, 1263.
3 Andersson’s group has made extensive use of the azabicyclo-
[2.2.1]heptene 4, as exemplified by P. Pinho and P. G. Andersson,
Chem. Commun., 1999, 597, and reference 5 therein; the Malpass group
has also developed the chemistry of these azabicyclic systems, as
exemplified by J. R. Malpass and C. D. Cox, Tetrahedron Lett., 1999,
40, 1419.
4 M. B. Hursthouse, K. M. A. Malik, D. E. Hibbs, S. M. Roberts, A. J. H.
Seago, V. Sik and R. Storer, J. Chem. Soc., Perkin Trans 1, 1995,
2419.
5 L. Stella, H. Abraham, J. Feneu-Dupont, B. Tinant and J. P. Declercq,
Tetrahedron Lett., 1990, 31, 2603; H. Abraham and L. Stella,
Tetrahedron, 1992, 48, 9707.
6 For a useful discussion of the Meisenheimer rearrangement, see V.
Rautenstrauch, Helv. Chim. Acta, 1973, 56, 2492, and references 8–18
therein.
7 For a study of the 2,3-Meisenheimer rearrangement of allyl N-oxides,
see Y. Yamamoto, J. Oda and Y. Inouye, J. Org. Chem., 1976, 41, 303,
and references therein; it might be noted that this process is believed to
be pericyclic rather than radical, and that 6 is (formally) the product of
the 2,3-Meisenheimer rearrangement of 5.
8 For the synthesis of 7-, 8- and 9-membered 1,2-oxaza ring systems via
the Meisenheimer rearrangement, see J. B. Bremner, E. J. Browne, P. E.
Davies and L. van Thuc, Aust. J. Chem., 1980, 33, 833; J. B. Bremner
E. J. Browne, P. E. Davies, C. L. Raston and A. H. White, Aust. J.
Chem., 1980, 33, 1323; J. B. Bremner E. J. Browne and P. E. Davies,
Aust. J. Chem., 1980, 33, 1335.
9 Spontaneous Meisenheimer rearrangements are rare, but has been
observed in the ring expansion of a highly strained azetidine N-oxide: T.
Kurihara, Y. Sakamoto, K. Tsukamoto, H. Ohishi, S. Harusawa and R.
Yoneda, J. Chem. Soc., Perkin Trans 1, 1993, 81.
10 O. Mitsunobu, Synthesis, 1981, 1.
11 N. Katagiri, M. Okada, Y. Morishita and C. Kaneko, Chem. Commun.,
1996, 2137.
Scheme 3 Conversion of the oxazabicyclooctanes 6 and 7 into hydroxylated
cyclopentylglycines such as 9 and 10. Conditions: (i) Zn–AcOH; (ii) H2 (50
psi)– Pd(OH)2/C; (iii) MeCN, reflux, 24 h. [R* = (S)-1-phenylethyl].
the di-radical must be retained within a solvent cage, is
extraordinary. Unprecedented, as far as we are aware, is the
establishment of an equilibrium with the Meisenheimer inter-
mediate (or possibly via heterolytic bond cleavage of 7),
providing a route by which the thermodynamically more stable
adduct 6 can be generated (see Scheme 2).
With an efficient route to two isomeric oxazabicyclooctanes
achieved, we wished to explore whether they could be
converted into hydroxy-substituted cyclopentylglycines. The
key transformations are shown in Scheme 3. In particular, Zn–
AcOH treatment of the [3.2.1] isomer 7 allowed selective
cleavage of the N–O bond, yielding the 4A-hydroxycyclopent-2A-
enyl glycine derivative 8. Hydrogenation of the double bond
(Pearlman’s catalyst, 50 psi) resulted in concomitant removal of
the a-methylbenzyl auxiliary to afford the 3A-hydroxycyclo-
pentyl glycine 9 as a single (2R,1AR,3AS) stereoisomer; the same
hydrogenation conditions also allowed direct conversion of 7 to
9 (90% yield). On the other hand, these hydrogenation
conditions enabled us to reduce the [3.3.0] isomer 6 directly to
the 2A-hydroxycyclopentyl glycine 10, also as a single
(2R,1AR,2AR) stereoisomer. Closely related analogues of 8 have
been used in the synthesis of cyclopentenylglycine,11 and of
carbocyclic analogues of nikkomycin12 and polyoxin C.13
In summary, the asymmetric aza-Diels–Alder adduct 4 reacts
with mCPBA to generate the Meisenheimer rearranged product
12 S. E. Ward, A. B. Holmes and R. McCague, Chem. Commun., 1997,
2085.
13 D. Zhang and M. J. Miller, J. Org. Chem., 1998, 63, 755; V. K.
Aggarwal and N. Monteiro, J. Chem. Soc., Perkin Trans. 1, 1997,
2531.
14 XSCANS X-ray Single Crystal Analysis System. Version 2.2. Bruker
AXS Inc., Madison, Wisconsin, USA, 1994.
15 G. M. Sheldrick, 1999. SHELXTL Version 5.1, Bruker AXS Inc.,
Madison, Wisconsin, USA.
2452
Chem. Commun., 2000, 2451–2452